ICH GCP - EU Clinical trials Registry

EudraCT Number: 2022-003588-55

Sponsor Protocol Number: 20221102

Start Date: 2024-10-14

Sponsor Name: Isala

Full Title: Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study

Medical condition: Oncology

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-004755-17

Sponsor Protocol Number: MYST-FACT

Start Date: 2024-10-01

Sponsor Name: FONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO

Full Title: PHASE I/II CLINICAL TRIAL OF ALLOGENEIC BONE MARROW DERIVED MESENCHYMAL STROMAL CELL THERAPY FOR THE PREVENTION AND TREATMENT OF PULMONARY FIBROSIS SECONDARY TO POST-INFECTIVE ARDS OR ALLOIMMUNE RE...

Medical condition: PULMONARY FIBROSIS SECONDARY TO ARDS OR ALLOIMMUNE REACTION AFTER TRANSPLANTATION

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	100000004855	10022619	Interstitial pulmonary fibrosis	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2022-002770-82

Sponsor Protocol Number: RR202200317

Start Date: 2024-09-09

Sponsor Name: Universitair Medisch Centrum Groningen

Full Title: The use of FAPI-PET/CT scan and FDG-PET?CT scan in acute phase Peyronie's disease for detection of active fibroblasts and inflammation in the penis - a pilot study

Medical condition: Peyronie's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10038604 - Reproductive system and breast disorders	10034766	Peyronies disease	LLT

Population Age: Elderly

Gender: Male

Trial protocol: NL (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2018-002373-22

Sponsor Protocol Number: hNSCALSII

Start Date: 2024-05-31

Sponsor Name: FONDAZIONE CASA SOLLIEVO DELLA SOFFERENZA OPERA DI SAN PIO DA PIETRELCINA OSPEDALE IRCCS

Full Title: Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis: A multicenter, randomized placebo controlled and biological endpoints clinical Trial

Medical condition: Amyotrophic Lateral Sclerosis (ALS)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2007-001152-39

Sponsor Protocol Number: SSG XX

Start Date: 2024-05-21

Sponsor Name: Scandinavian Sarcoma Group

Full Title: SSGXX A Scandinavian Sarcoma Group treatment protocol for adult patients with non-metastatic high-risk soft tissue sarcoma of the extremities and trunk wall

Medical condition: SSG XX is a phase II trial for high-risk soft tissue sarcoma(STS) of the extremities and trunk wall. Prognostic markers are used to identify high-risk tumors. SSG XX will evaluate chemo-and radioth...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NO (Completed) SE (Completed)

Trial results: (No results available)

EudraCT Number: 2020-004231-25

Sponsor Protocol Number: MS201923_0050

Start Date: 2024-05-21

Sponsor Name: Merck Healthcare KGaA

Full Title: A Phase II, open-label, single-arm study of berzosertib (M6620) in combination with topotecan in participants with relapsed platinum-resistant small-cell lung cancer

Medical condition: Relapsed platinum resistant small-cell lung cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041067	Small cell lung cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) IT (Completed) ES (Temporarily Halted)

Trial results: (No results available)

EudraCT Number: 2020-004633-21

Sponsor Protocol Number: APHP191047

Start Date: 2024-04-29

Sponsor Name: Assistance Publique -Hopitaux de Paris

Full Title:

Medical condition:

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2020-003745-11

Sponsor Protocol Number: 1346-0014

Start Date: 2024-03-02

Sponsor Name: Boehringer Ingelheim

Full Title: An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)

Medical condition: Schizophrenia

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10037175 - Psychiatric disorders	10039626	Schizophrenia	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: FR (Trial now transitioned) CZ (Trial now transitioned) ES (Ongoing) SK (Trial now transitioned) HU (Trial now transitioned) NO (Trial now transitioned) DK (Trial now transitioned) LT (Trial now transitioned) IT (Trial now transitioned) GR (Trial now transitioned) BE (Trial now transitioned) SE (Trial now transitioned) NL (Trial now transitioned) FI (Trial now transitioned) HR (Trial now transitioned) AT (Trial now transitioned) BG (Ongoing) PT (Trial now transitioned) RO (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2023-000005-12

Sponsor Protocol Number: CRCFC-TEICO.SA.2022

Start Date: 2024-02-21

Sponsor Name: AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA

Full Title: An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa) infections in CYSTIC FIBROSIS PATIENTS

Medical condition: cystic fibrosis associated to persistent Staphylococcus aureus (including MRSA) infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10011762	Cystic fibrosis	PT
	20.0	100000004862	10075981	Staphylococcus aureus infection	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2022-003922-27

Sponsor Protocol Number: PAM-UMCG-002

Start Date: 2024-02-08

Sponsor Name: University Medical Center Groningen (UMCG)

Full Title: Neo-adjuvant Pembrolizumab as alternative to radio(chemo)therapy in MMRd uterine cancer

Medical condition: Primary uterine cancer characterized with dMMR

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

Poslední zkoušky

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence